KRYS
Krystal Biotech Inc
345.80$
+0.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -248.1% | -17.2% | 35.1% | -5.9% | 70.2% | 58.0% | 35.1% | 54.9% | 40.6% | 72.4% | 69.1% | 62.7% | 61.8% | |
| 16.0% | 3.6% | 3.6% | 2.9% | 1.8% | 1.7% | 1.9% | 1.6% | 1.6% | 1.6% | 1.3% | 1.1% | 1.4% | |
| 97.1% | 23.4% | 20.6% | 18.7% | 15.9% | 14.7% | 15.3% | 14.7% | 13.4% | 12.9% | 11.7% | 11.9% | 12.4% | |
| -110.9% | -61.0% | 13.9% | -47.4% | 21.7% | -6.2% | -21.0% | 0.5% | -28.5% | 8.9% | 12.0% | 2.4% | -0.3% | |
| 20.8% | 4.4% | 2.8% | 1.6% | 1.2% | 0.9% | 7.0% | 2.0% | 1.7% | 2.0% | 6.1% | 3.0% | 3.3% | |
| 1,229.5% | -24.1% | -57.4% | -27.5% | -40.9% | -91.9% | -62.1% | -11.0% | -4.4% | 10.4% | -54.6% | -135.5% | -49.6% | |
| – | – | – | – | – | – | – | – | – | – | -14.6% | -0.1% | – | |
| 156.5% | 6.2% | 23.4% | 15.1% | 4.0% | 2.7% | -14.1% | 1.9% | 3.8% | 14.6% | -9.0% | 12.6% | 5.4% | |
| 1,138.0% | -35.4% | 1.5% | -18.8% | 33.6% | -31.9% | -40.9% | 46.9% | 39.6% | 96.8% | 4.3% | -61.7% | 16.8% | |
| -268.9% | -21.5% | 32.3% | -7.5% | 69.0% | 57.1% | 28.1% | 52.9% | 38.8% | 70.4% | 62.9% | 59.7% | 58.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.